ExploreWatchlistsPricing
  1. JP-listed companies
  2. TERUMO CORPORATION
  3. Financials
  4. Diluted EPS

TERUMO CORPORATION (4543)

Market cap
¥3.29T
P/E ratio
19.8x
Terumo develops medical devices and solutions for heart treatment, clinical care, and blood technology to support healthcare delivery worldwide.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndDiluted EPS (JPY)YoY (%)
Mar 31, 202692.1+16.62%
Mar 31, 202579+10.52%
Mar 31, 202471.5-39.92%
Mar 31, 2023119+1.34%
Mar 31, 2022117.4+14.95%
Mar 31, 2021102.1-9.32%
Mar 31, 2020112.6+7.28%
Mar 31, 2019105-47.47%
Mar 31, 2018199.8+42.69%
Mar 31, 2017140+10.83%
Mar 31, 2016126.4+27.48%
Mar 31, 201599.1+10.40%
Mar 31, 201489.8

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat